Therapeutic targeting of innate immunity in the failing heart.

Therapeutic targeting of innate immunity in the failing heart.

Item
http://www.wikidata.org/entity/Q37809215
Non-coding RNAs in cardiac hypertrophy.Loss of MD1 exacerbates pressure overload-induced left ventricular structural and electrical remodelling.Cardiopulmonary exercise capacity and preoperative markers of inflammation.Expression of Adiponectin Receptors on Peripheral Blood Leukocytes of Hypertensive Children Is Associated with the Severity of HypertensionToll-like receptors 2 and 4 modulate autonomic control of heart rate and energy metabolismToll-interacting protein (Tollip) negatively regulates pressure overload-induced ventricular hypertrophy in miceA novel 72-kDa leukocyte-derived osteoglycin enhances the activation of toll-like receptor 4 and exacerbates cardiac inflammation during viral myocarditis.The emerging role of innate immunity in the heart and vascular system: for whom the cell tolls.Innate immune receptors in heart failure: Side effect or potential therapeutic target?Skeletal muscle inflammation and atrophy in heart failure.Pediatric and adult dilated cardiomyopathy represent distinct pathological entities.BEX1 is an RNA-dependent mediator of cardiomyopathy.T helper cells with specificity for an antigen in cardiomyocytes promote pressure overload-induced progression from hypertrophy to heart failure.BNP in heart failure: even leucocytes cannot escape its influence.Toll-like receptor 4 knockout protects against isoproterenol-induced cardiac fibrosis: the role of autophagy.The Role of Toll-Like Receptor Signaling in the Progression of Heart Failure.
P2860

Therapeutic targeting of innate immunity in the failing heart.

Item
http://www.wikidata.org/entity/Q37809215
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年学术文章
@wuu
2010年学术文章
@zh-cn
2010年学术文章
@zh-hans
2010年学术文章
@zh-my
2010年学术文章
@zh-sg
2010年學術文章
@yue
2010年學術文章
@zh
2010年學術文章
@zh-hant
name
Therapeutic targeting of innate immunity in the failing heart.
@en
Therapeutic targeting of innate immunity in the failing heart.
@nl
type
label
Therapeutic targeting of innate immunity in the failing heart.
@en
Therapeutic targeting of innate immunity in the failing heart.
@nl
prefLabel
Therapeutic targeting of innate immunity in the failing heart.
@en
Therapeutic targeting of innate immunity in the failing heart.
@nl
P1433
P1476
P2093
P2860
P304
P31
P356
P433
P478
P50
P577
P5875
P698
P932
P356
P1433
P1476
Therapeutic targeting of innate immunity in the failing heart.
@en
P2093
P2860
P304
P31
P356
10.1016/J.YJMCC.2010.11.003
P433
P478
P50
P577
P5875
P698
P932